Pulmonary Drugs Market: Entry of Generic Versions of Blockbuster Pulmonary Drugs to Hamper Growth Prospects
With the growing population reeling under the high incidence of chronic respiratory diseases, the global pulmonary drugs market is likely to find immense growth opportunities in the forthcoming years. As per the forum of international respiratory societies (FIRS), chronic obstructive pulmonary disease (COPD) affects nearly 200 million lives globally and has thus become the fourth leading cause of death.
View full press release